Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma
Lauri M. Burroughs(Fred Hutch Cancer Center), David G. Maloney(Fred Hutch Cancer Center), Leo Luznik(Sidney Kimmel Comprehensive Cancer Center), Richard J. Jones(Sidney Kimmel Cancer Center), Benedetto Bruno(University of Turin), Dietger Niederwieser(Leipzig University of Applied Sciences), Paul V. O’Donnell(Johns Hopkins Hospital), Ephraim J. Fuchs(Johns Hopkins Hospital), Richard F. Ambinder(Johns Hopkins University), Barry E. Storer(City Of Hope National Medical Center), Richard T. Maziarz(Oregon Health & Science University), Brenda M. Sandmaier(University of Washington), Rainer Storb(City Of Hope National Medical Center), Finn Bo Petersen(Intermountain Healthcare), Karl G. Blume(City Of Hope National Medical Center), Michael A. Pulsipher(Children's Hospital of Los Angeles), Michael B. Maris(Colorado Blood Cancer Institute), Heather J. Symons(Johns Hopkins University)
Cited by 264
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k